Indirect immunotargeting of CIS‐PT to human epidermoid carcinoma KB using the avidin‐biotin system
Authors:
- 10 May 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (2) , 167-172
Abstract
Cis‐diamminedichloroplatinum (II) (cis‐Pt) complexed to a carboxymethyl dextran‐avidin conjugate was targeted to biotin‐monoclonal antibody 108 (b‐MAb108). This MAb recognizes the extracellular domain of the epidermal growth factor receptor (EGF‐R) on human epidermoid carcinoma (KB) cells over‐expressing EGF‐R. Cis‐Pt‐carboxymethyl‐dextran‐avidin (Pt‐dex‐Av) containing 60–90 M cis‐Pt/M avidin was administered 24 hr following b‐MAb108 containing 3–5 M biotin/ M MAb. This treatment was potentially more effective in suppressing the growth of established KB tumor xenografts, or in inhibiting the development of lung metastases in nude mice, than free MAb 108, free drug or MAb 108 followed by drug. Replacing b‐MAb108 by unbiotinylated antibody or by b‐MAb of a different specificity also yielded lower suppressive effects. The sequential administration of Pt‐dex‐Av following b‐MAb was more effective than Introduction, of the Pt‐dex‐Av when already complexed to b‐MAb 108. The results presented in this preliminary investigation suggest that Pt‐dex‐Av is specifically removed from the circulation by b‐MAb 108 concentrated at the tumor site.Keywords
This publication has 12 references indexed in Scilit:
- Tissue distribution of avidin and streptavidin injected to miceEuropean Journal of Biochemistry, 1990
- Soluble polymers as carriers of cis-platinumJournal of Controlled Release, 1989
- Blood levels and serum protein binding of cis-Platinum(II) complexed to carboxymethyl-dextranCancer Chemotherapy and Pharmacology, 1989
- Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.Proceedings of the National Academy of Sciences, 1989
- Efficacy of Antibodies to Epidermal Growth Factor Receptor Against KB Carcinoma In Vitro and in Nude MiceJNCI: Journal of the National Cancer Institute, 1988
- In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: A strategy to increase tumor radiolocalizationInternational Journal of Cancer, 1988
- Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextranCancer Immunology, Immunotherapy, 1987
- Limiting factors in the localization of tumours with radiolabelled antibodiesImmunology Today, 1985
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980
- A Spectrophotometric Assay for Avidin and Biotin Based on Binding of Dyes by AvidinBiochemical Journal, 1965